학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 87,402건 | 목록 1~20
eBook
Clinical and Preclinical Models for Maximizing Healthspan: Methods and Protocols. 03/27/2020. 2138:175-183
Report
A Phase III, Open-Label, Randomized Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
Academic Journal
Li Y; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.; Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China.; Du W; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.; Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China.; Graduate School of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.; Shan C; Department of Medical Imaging, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.; Yu Z; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.; An J; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.; Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China.; Dong Z; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.; Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China.
Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE
Academic Journal
Du W; Graduate School, Hebei Medical University, Shijiazhuang, China.; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China.; Liu Z; Graduate School, Hebei Medical University, Shijiazhuang, China.; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China.; Wang Z; Graduate School, Hebei Medical University, Shijiazhuang, China.; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China.; Zhou X; Graduate School, Hebei Medical University, Shijiazhuang, China.; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China.; Dong Z; Graduate School, Hebei Medical University, Shijiazhuang, China.; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China.; Li Y; Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China.
Publisher: PeerJ Inc Country of Publication: United States NLM ID: 101603425 Publication Model: eCollection Cited Medium: Internet ISSN: 2167-8359 (Electronic) Linking ISSN: 21678359 NLM ISO Abbreviation: PeerJ Subsets: MEDLINE
Academic Journal
Zhang M; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Saifu Glotope Laboratories Wuxi, Wuxi, 214000, China.; Zhou X; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Li Z; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Zhao T; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Miao Y; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Liu S; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.; Han Q; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Biohit Healthcare (Hefei) Co., Ltd, Hefei, 2300000, China.; Wang L; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Xu Y; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Cui T; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China. cuitao0909@126.com.; Hefei Tianhui Biotechnology Co., Ltd, Hefei, 230000, China. cuitao0909@126.com.; Wang Z; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China. wangze9452@163.com.; Yi X; Hefei Tianhui Biotechnology Co., Ltd, Hefei, 230000, China.; Tianjin Joint Innovation Biotechnology Co., Ltd, Tianjin, 300301, China.; Yan F; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.; Tianjin Joint Innovation Biotechnology Co., Ltd, Tianjin, 300301, China.; Wang X; State Key Laboratory of Druggability Evatuation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, China.
Publisher: Biomed Central Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE
Academic Journal
Xu J; Nanjing University Medical School, Nanjing, China.; Wang B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University; MOE Innovation Center for Basic Research in Tumor Immunotherapy; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China.; Liu Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University; MOE Innovation Center for Basic Research in Tumor Immunotherapy; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China.; Guo S; Crown Bioscience Inc, Suzhou, China.; Chen C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University; MOE Innovation Center for Basic Research in Tumor Immunotherapy; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China.; Wu J; Medical College, Yangzhou University, Yangzhou, China.; Zhao X; Nanjing University Medical School, Nanjing, China.; Li M; Nanjing University Medical School, Nanjing, China.; Ma Z; Nanjing University Medical School, Nanjing, China.; Zhou S; Nanjing University Medical School, Nanjing, China.; Qian Y; Nanjing University Medical School, Nanjing, China.; Huang Y; School of Medicine, University of Missouri, Columbia, USA.; Wang Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University; MOE Innovation Center for Basic Research in Tumor Immunotherapy; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China.; Shu C; Department of Bioinformatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, China.; Xu Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University; MOE Innovation Center for Basic Research in Tumor Immunotherapy; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China. Electronic address: xqx2016nj@sina.com.; Ben J; Department of Pathophysiology, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China. Electronic address: bjj@njmu.edu.cn.; Wang Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University; MOE Innovation Center for Basic Research in Tumor Immunotherapy; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China. Electronic address: wangqiang@ahmu.edu.cn.; Wang S; Nanjing University Medical School, Nanjing, China; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University; MOE Innovation Center for Basic Research in Tumor Immunotherapy; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China; Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China. Electronic address: sywang@nju.edu.cn.
Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9815369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2084 (Electronic) Linking ISSN: 13687646 NLM ISO Abbreviation: Drug Resist Updat Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Sorafenib
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어